Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
about
Prolonged-release formulation of melatonin (Circadin) for the treatment of insomniaProlonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trialRepeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocolMelatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature.Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover studyMelatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials.Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials.Daily rhythms of the sleep-wake cycle.The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial.Sleep disturbances in adult survivors of childhood brain tumorsSleep in older adults: normative changes, sleep disorders, and treatment options.Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countriesOver-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and SafetyMood disorders, circadian rhythms, melatonin and melatonin agonists.Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults.Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain.Drugs for insomnia.Cardiovascular effects of melatonin receptor agonists.Current Phase II investigational therapies for insomnia.The Role of Melatonin in the Treatment of Primary Headache Disorders.Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people.Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.Pharmacotherapy of Insomnia.
P2860
Q22306021-FADCEE5D-F251-40AA-97BF-915F846AA179Q28387407-7AD2978A-09A5-41C1-BB2C-A08049E9A712Q34033768-87DA1824-9AC9-409D-911E-000F6DFB1D35Q34041023-0076406C-C762-4E44-A317-581387AA7645Q34304485-CD161F2D-D015-4C66-A687-F9E8C45AF1ECQ34358480-A8C2C223-84BD-45EC-8AE8-833BB93B06BAQ34632640-5177B346-872D-4AFC-992D-2ACC394D28BAQ34753677-47C228AB-D673-4281-9919-FA21BB455C84Q35147981-5761D2D0-FE0D-4796-9953-D29256FF62A5Q35178803-16D02A79-3F4D-474E-A9EB-A12FCF263C7AQ35547735-1278B71D-DDBA-49AC-8A61-23E24B9673B6Q35752989-E3F71EEA-243F-467B-A3CF-969F1094A86CQ36031520-7A3D30E4-9682-4F6F-99FE-1CF89C732645Q36111903-E6A4334A-3A61-47AB-800E-E13EEF65411FQ36233622-9387F09F-AC1A-4453-A37F-19C591D8255AQ36307859-9176C21A-6B53-404F-AB63-583C75675E76Q36722184-16798DE1-3780-4529-AE55-4A779B448AF6Q36722961-70880EE1-0056-4118-A319-4DFDF1A6196DQ36748061-F90F88C3-7B16-4230-9581-55778B475A1CQ36928856-CEDB8DA6-AC0F-4FF6-B3C8-F6E5FEA58F29Q37578651-13B93E2C-43B3-4563-835A-E0C9070C61F0Q38017272-23F646AD-3DAB-4414-AB4E-07B44EAC1B49Q38037124-56387238-4756-4808-8168-36CEDBD8F9ABQ38271292-1FCEDA8E-BA08-48C4-A67E-CA8844765A38Q38851513-9560CB79-4891-459D-A7A7-35D40BA6F1C3Q39044821-09A4600C-25A2-4F22-835D-CD0345778E89Q41001443-7638E833-2A4B-4873-84B1-6CF48503FD44Q46261270-F8B3FB7E-C3D2-40E7-BC77-72AA13CDF228Q47554377-4E6B0628-8D7A-42E9-B411-A431234092CEQ48317386-3BAE00DA-5655-4736-8E24-09F0D423127BQ55463269-2451D0B9-D643-4DDD-9CF6-EB83B0734DF4
P2860
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nightly treatment of primary i ...... dictors of efficacy and safety
@ast
Nightly treatment of primary i ...... dictors of efficacy and safety
@en
Nightly treatment of primary i ...... dictors of efficacy and safety
@en-gb
Nightly treatment of primary i ...... dictors of efficacy and safety
@nl
type
label
Nightly treatment of primary i ...... dictors of efficacy and safety
@ast
Nightly treatment of primary i ...... dictors of efficacy and safety
@en
Nightly treatment of primary i ...... dictors of efficacy and safety
@en-gb
Nightly treatment of primary i ...... dictors of efficacy and safety
@nl
prefLabel
Nightly treatment of primary i ...... dictors of efficacy and safety
@ast
Nightly treatment of primary i ...... dictors of efficacy and safety
@en
Nightly treatment of primary i ...... dictors of efficacy and safety
@en-gb
Nightly treatment of primary i ...... dictors of efficacy and safety
@nl
P2093
P2860
P921
P356
P1433
P1476
Nightly treatment of primary i ...... dictors of efficacy and safety
@en
P2093
Alan G Wade
Alex McConnachie
Gordon Crawford
Moshe Laudon
Nava Zisapel
P2860
P2888
P356
10.1186/1741-7015-8-51
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1005887281